Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Currently, Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.

IMS Consulting Group is the world’s leading specialized advisor on critical strategic and commercial issues in life sciences. With a deep industry focus, evidence-based insights, analytical drive and a presence across five continents, IMSCG partners with leading pharmaceutical, biotech and other life sciences clients to help optimize decision making and maximize future value.

River Associates Investments LLC was founded in 1989 as a private equity partner for management teams in buyouts, divestitures and recapitalizations of lower middle market companies. River Associates has invested in companies operating in a wide variety of industries including manufacturing, high-margin distribution, industrial services and select retail businesses. The firm invests throughout the United States and Canada and focuses primarily on companies with adjusted operating income (EBITDA) ranging from $2-10 million.

Member, American Academy of OphthalmologyDiplomate, American Board of Ophthalmology

Chief ResidentVolunteer, Project ORBIS